Molecular Oncology
Volume 4, Issue 2 , Pages 98-118, April 2010

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression

  • Ivan O. Potapenko

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Faculty of Medicine, Oslo University, Norway
  • ,
  • Vilde D. Haakensen

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Faculty of Medicine, Oslo University, Norway
  • ,
  • Torben Lüders

      Affiliations

    • Institute for Clinical Epidemiology and Molecular Biology (Epi-Gen), Faculty Division Akershus University Hospital, Faculty of Medicine, Oslo, Norway
  • ,
  • Åslaug Helland

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway
  • ,
  • Ida Bukholm

      Affiliations

    • Institute for Clinical Epidemiology and Molecular Biology (Epi-Gen), Faculty Division Akershus University Hospital, Faculty of Medicine, Oslo, Norway
    • Department of Surgery, Akershus University Hospital, Oslo, Norway
  • ,
  • Therese Sørlie

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Institute for Informatics, Faculty of Natural Sciences and Mathematics, University of Oslo, Norway
  • ,
  • Vessela N. Kristensen

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Institute for Clinical Epidemiology and Molecular Biology (Epi-Gen), Faculty Division Akershus University Hospital, Faculty of Medicine, Oslo, Norway
  • ,
  • Ole C. Lingjærde

      Affiliations

    • Institute for Informatics, Faculty of Natural Sciences and Mathematics, University of Oslo, Norway
  • ,
  • Anne-Lise Børresen-Dale

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway
    • Faculty of Medicine, Oslo University, Norway
    • Corresponding Author InformationCorresponding author at: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0310 Oslo, Norway. Tel.: +47 22 78 13 33.

Received 20 October 2009; received in revised form 2 December 2009; accepted 2 December 2009. published online 21 December 2009.

Abstract 

Glycosylation is the stepwise procedure of covalent attachment of oligosaccharide chains to proteins or lipids, and alterations in this process have been associated with malignant transformation. Simultaneous analysis of the expression of all glycan-related genes clearly gives the advantage of enabling a comprehensive view of the genetic background of the glycobiological changes in cancer cells. Studies focusing on the expression of the whole glycome have now become possible, which prompted us to review the present knowledge on glycosylation in relation to breast cancer diagnosis and progression, in the light of available expression data from tumors and breast tissue of healthy individuals. We used various data resources to select a set of 419 functionally relevant genes involved in synthesis, degradation and binding of N-linked and O-linked glycans, Lewis antigens, glycosaminoglycans (chondroitin, heparin and keratan sulfate in addition to hyaluronan) and glycosphingolipids. Such glycans are involved in a number of processes relevant to carcinogenesis, including regulation of growth factors/growth factor receptors, cell–cell adhesion and motility as well as immune system modulation. Expression analysis of these glycan-related genes revealed that mRNA levels for many of them differ significantly between normal and malignant breast tissue. An associative analysis of these genes in the context of current knowledge of their function in protein glycosylation and connection(s) to cancer indicated that synthesis, degradation and adhesion mediated by glycans may be altered drastically in mammary carcinomas. Although further analysis is needed to assess how changes in mRNA levels of glycan genes influence a cell's glycome and the precise role that such altered glycan structures play in the pathogenesis of the disease, lessons drawn from this study may help in determining directions for future research in the rapidly-developing field of glycobiology.

Keywords: Breast cancer, Expression profiling, Glycosylation, N/O-linked glycans, Glycosaminoglycans, Glycosphingolipids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(09)00155-0

doi:10.1016/j.molonc.2009.12.001

Molecular Oncology
Volume 4, Issue 2 , Pages 98-118, April 2010